Assessing Health-Related Quality of Life for Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome-Reference-Cited by-同舟云学术

Assessing Health-Related Quality of Life for Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome

Published:2014-02-01 Issue:2 Volume:150 Page:169
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Mathias Susan D.¹,Chren Mary-Margaret²,Colwell Hilary H.¹,Yim Yeun Mi³,Reyes Carolina³,Chen Diana M.³,Fosko Scott W.⁴

Affiliation:

1. Health Outcomes Solutions, Winter Park, Florida

2. Department of Dermatology, University of California, San Francisco

3. Genentech Inc, South San Francisco, California

4. Departments of Dermatology, Internal Medicine, Otolaryngology–Head and Neck Surgery, and Ophthalmology, Saint Louis University School of Medicine, Saint Louis University Cancer Center, St Louis, Missouri

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial;Future Oncology;2024-07-29

2. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies;American Journal of Clinical Dermatology;2024-06-19

3. Qualitative Patient Interviews to Characterize the Human Burden of Advanced Basal Cell Carcinoma Following Hedgehog Pathway Inhibitor Treatment;Dermatology and Therapy;2023-06-17

4. Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks;JAAD International;2023-03

5. Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?;Cancers;2021-11-22